Prednisone Recruiting Phase 3 Trials for Leukemia, Lymphoblastic, Acute, Philadelphia-Positive / Acute Lymphoblastic Leukaemias (ALL) / Ph1 Chromosome / Acute Lymphocytic Leukemia (ALL) / Leukaemia, Lymphoblastic / Lymphoblastic Leukemia, Acute, Adult Treatment

RecruitingTreatment3 IdentifierTitleDrugs
NCT03589326An Efficacy Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Participants With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)